June 11, 2026

Sander Wuyts on Simon's Bench Talk: How to find the T cells that matter

Sander Wuyts, co-founder and CEO of ImmuneWatch, joined the Simon's Bench Talk podcast to discuss how ImmuneWAtch DETECT turns immune receptor sequencing data into functional insight.

The conversation covers how a single blood draw can function as an immune passport, the role of DETECT in Phase 1 oncology trials using single-cell resolution, and how personalised vaccine development benefits from feedback loops that identify tumour-specific T cell targets.

Listen to the full episode on YouTube or Spotify.

Listen to the episode

Stay up to date

Subscribe to our newsletter to receive useful tips and information.

Thank you! Your submission has been received!

Oups ! Un problème s'est produit lors de l'envoi du formulaire.

Recommended articles

September 18, 2025

Using ImmuneWatch DETECT within Platforma to annnotate epitope and HLA specificity of TCRs

This webinar dives into the latest discoveries linking Epstein-Barr Virus (EBV) to Primary Sclerosing Cholangitis (PSC) and demonstrates how large-scale immune profiling technologies, including TCR sequencing (TCR-seq), reveal critical insights into adaptive immune responses.

October 22, 2025

Webinar: Annotating antigen specificity of T-cell receptor repertoires in clinical oncology

In our upcoming webinar are taking a deeper dive into this question and will explore how TCR-epitope annotation models can help you formulate an answer. We’ll discuss what the limitations of such bioinformatic models are and where there are opportunities to enrich your data analysis.